William Blair Investment Management LLC held its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,841 shares of the medical instruments supplier’s stock at the end of the second quarter. William Blair Investment Management LLC’s holdings in DENTSPLY SIRONA were worth $2,000,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the stock. BB&T Securities LLC raised its position in shares of DENTSPLY SIRONA by 59.2% in the second quarter. BB&T Securities LLC now owns 7,056 shares of the medical instruments supplier’s stock valued at $457,000 after buying an additional 2,623 shares during the period. KBC Group NV raised its position in shares of DENTSPLY SIRONA by 18.3% in the second quarter. KBC Group NV now owns 23,055 shares of the medical instruments supplier’s stock valued at $1,495,000 after buying an additional 3,573 shares during the period. Cidel Asset Management Inc. raised its position in shares of DENTSPLY SIRONA by 1.5% in the second quarter. Cidel Asset Management Inc. now owns 326,349 shares of the medical instruments supplier’s stock valued at $21,160,000 after buying an additional 4,913 shares during the period. Bridgewater Wealth & Financial Management LLC purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $214,000. Finally, Ballentine Partners LLC purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $203,000. 93.97% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 54.80 on Monday. DENTSPLY SIRONA Inc. has a 52-week low of $52.53 and a 52-week high of $65.68. The company’s market capitalization is $12.58 billion. The company’s 50-day moving average price is $59.93 and its 200 day moving average price is $62.08.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.65. The business had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business’s revenue was down 2.9% on a year-over-year basis. During the same period last year, the company posted $0.76 EPS. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is presently -10.09%.

TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA Inc. (XRAY) Position Maintained by William Blair Investment Management LLC” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and republished in violation of United States & international copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/08/28/dentsply-sirona-inc-xray-position-maintained-by-william-blair-investment-management-llc.html.

XRAY has been the topic of several recent research reports. UBS AG reiterated a “neutral” rating and set a $59.00 price objective (down from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. BidaskClub lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Jefferies Group LLC reduced their price objective on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a research report on Wednesday, August 23rd. Stifel Nicolaus reiterated a “buy” rating and set a $66.00 price objective (down from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Finally, Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, August 14th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $66.08.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.